▲ Peaking
Health
Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak
Moderna has launched a Phase 1 clinical trial for an Ebola vaccine targeting the specific strain causing the current outbreak in the Democratic Republic of Congo.